Conference abstract · 21 Sep 2020
Mini reviewPublished 11 Apr 2016
Epigenetics of Brain Disorders: The Paradigm of Alzheimer's Disease
Chairman of Genomic Medicine, Camilo Jose Cela University, Madrid, Spain; EuroEspes Biomedical Research Center, Institute of Medical Science and Genomic Medicine, Corunna, Spain
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Over 80% of brain disorders are associated with multiple genomic defects in conjunction with environmental factors and epigenetic phenomena. Classical epigenetic mechanisms, including DNA methylation, histone modifications, and microRNAs (miRNAs) regulation, are among the major regulatory elements that control metabolic pathways at the molecular level, with epigenetic modifications controlling gene expression transcriptionally and miRNAs suppressing gene expression post-transcriptionally. Epigenetic modifications are related to disease development, environmental exposure, drug treatment and aging. Epigenetic changes are reversible and can be potentially targeted by pharmacological intervention. Both hypermethylation and hypomethylation of DNA, chomatin changes and miRNA dysregulation are common in age-related disorders and in many neuropsychiatric, neurodevelopmental and neurodegenerative disorders. Major epigenetic mechanisms may contribute to Alzheimer’s disease (AD) pathology. Several pathogenic genes and many other AD-related susceptibility genes contain methylated CpG sites. AD brains exhibit a genome-wide decrease in DNA methylation. Pathogenic histone modifications are present in AD. Alterations in epigentically regulated miRNAs may contribute to the abnormal expression of pathogenic genes in AD. Epigenetic drugs can reverse epigenetic changes in gene expression and might open future avenues in AD therapeutics. Individual differences in drug response are associated with genetic and epigenetic variability and disease determinants. Pharmacoepigenomics deals with the influence that epigenetic alterations may exert on genes involved in the pharmacogenomic network (pathogenic, mechanistic, metabolic, transporter, and pleiotropic genes) responsible for the pharmacokinetics and pharmacodynamics of drugs (efficacy and safety), as well as the effects that drugs may have on the epigenetic machinery.
Keywords
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 2018
Exploring the kaleiodoscopic oasis of epigenetics-based diet, brain games and physical exercises in cognitive aging and Alzheimer dementia: Evidence, promises and challenges
Conference abstract · 1 Sep 2015
Exploring the kaleiodoscopic oasis of epigenetics-based diet, brain games and physical exercises in cognitive aging and Alzheimer dementia: Evidence, promises and challenges
Short communication · 29 Jul 2020
Brain Disorders 2020: Stimulation of cerebral neurogenesis with transcatheter intracerebral laser revascularization (photobiomodulation) in patients with Alzheimers disease
Short communication · 29 Jul 2020
Brain Disorders 2020: Brain insulin resistance: Targeting PI3K/AKT/GSK3-β pathway in Intracerebroventricular-streptozocin induced rat model of Alzheimers disease
More from this journal
The newest in Journal of Alzheimers Disease & Parkinsonism.
Commentary · 8 Jun 2026
Cognitive Concerns: The Side Effects of Surgery in Alzheimer's Patients
Perspective · 8 Jun 2026
Oxidative Stress and Its Role in Neuronal Degeneration: Mechanisms and Implications
Commentary · 8 Jun 2026
Understanding the Pathophysiology of Prion-Induced Dementia
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Alzheimers Disease & Parkinsonism
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Ramón Cacabelos”
